F. Aube

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair

This study shows that MAPK inhibitors reduce aspartate and glutamate in melanoma cells, leading to DNA repair defects and increased mutations through metabolic adaptation.

Efficient genome editing in primary cells and in vivo using viral-derived "Nanoblades" loaded with Cas9/sgRNA ribonucleoproteins